Oculogenex Inc.

Dallas, TX

UEI
K6P8KFEVG5D5
CAGE
8S4G5
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Minority Owned Business
  • Subcontinent Asian (Asian-Indian) American Owned
  • Woman Owned Business
  • Woman Owned Small Business
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
3060 Pegasus Park Dr, Dallas, TX 75247, USA
Website
oculogenex.com
Founded
2020
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Pharmaceuticals
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Developing a gene therapy-based solution for early intervention in age related macular degeneration (AMD) to prevent… R44EY038510 National Eye Institute (NIH) $1,092,536
Sbir phase II: preclinical validation of an ocular antioxidant enhancing gene delivery vehicle for dry macular… 2208096 National Science Foundation $1,199,722
Sbir phase i: preclinical validation of an ocular antioxidant enhancing gene delivery vehicle to target dry macular… 2111704 Division of Industrial Innovation $256,000

Quick answers

Is Oculogenex Inc. registered in SAM.gov?

Yes. Oculogenex Inc.'s SAM.gov registration is active through July 30, 2027.

What is Oculogenex Inc.'s most recent federal award?

Oculogenex Inc.'s most recent federal grant award is Developing a gene therapy-based solution for early intervention in age related macular degeneration (AMD) to prevent… (R44EY038510), from National Eye Institute (NIH), on August 1, 2026.

On GovTribe

See Oculogenex Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login